CCAN 0.750   +0.032 +4.50% Updated: 04-18-2017 $CCAN

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
80
CCAN 0.750   +0.032 +4.50% Updated: 04-18-2017 $CCAN
Last Trade: 4/18/2017 3:44:00 PM
Last 0.750   +0.032 +4.50%
Open 0.750
Previous Close 0.718
Day High / Low 0.780 / 0.740
Year High / Low 30.000 / 0.400
Volume 88,383
Projected Volume 88383 (109%)
# of Trades / Projected 76 / 76
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle NEUTRAL
Volatility Today MEDIUM
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 100%
From 80 Day High 100%
From 150 Day High 69%
From 40 Day Low 234%
From 80 Day Low 234%
From 150 Day Low 234%
Pivot Analysis
Price Pivot $ 0.760
Day Resistance 1 $ 0.770
Day Support 1 $ 0.730
Day Resistance 2 $ 0.800
Day Support 2 $ 0.720
Consolidations
Short Term YES
Medium Term NO
Long Term NO
Volume Indicators
20 Day Avg Vol 81,442
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 66,443
Today / 150 Day Avg Vol ABOVE
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bearish
Stochastics neutral
RSI neutral
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday HIGH
10 Day Volatility DECREASING
20 Day Volatility INCREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals to Showcase Research on Membranous Nephropathy

Updated Category News Views 167

ANI Pharmaceuticals to Present Research at ASN Kidney Week 2024 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is set to unveil exciting new pre-clinical data regarding its membranous nephropathy (MN) research. The presentations will take place during two poster sessions at the esteemed American Society of Nephrology (ASN) Kidney Week 2024. The Significance of the ASN Kidney...

Continue Reading
Alexander & Baldwin Reveals Details of 2024 Dividend Payments

Updated Category News Views 205

Alexander & Baldwin's Dividend Announcements for 2024 Alexander & Baldwin, Inc. (NYSE: ALEX) has recently shared significant details regarding the allocation of dividend distributions for the year 2024. This announcement underscores the company's commitment to providing valuable returns to its shareholders while enhancing its operations within the commercial real estate...

Continue Reading
Northern 2 VCT PLC Subscription Offer Fully Secured

Updated Category News Views 162

Update on Subscription Offer by Northern 2 VCT PLC Northern 2 VCT PLC has completed a significant milestone in its financing efforts. The company recently announced that its offer for new ordinary shares for subscription is now fully subscribed, raising a total of up to £10 million. This development comes ahead of the allotment date, signaling a strong interest in the...

Continue Reading
Georgia Power Launches Flexible Payment Plans for Customers

Updated Category News Views 181

Georgia Power Introduces New Payment Options for Customers In an effort to assist customers affected by recent disasters, Georgia Power has rolled out its innovative Installment Payment Plans. This initiative allows customers to spread their current account balance over several months, making it easier for them to manage their finances as they recover. Flexible Payment...

Continue Reading
Exciting New Luxury Home Community Launch in Springs Soon

Updated Category News Views 61

Toll Brothers Announces Foxtail Crossing Community Toll Brothers, Inc. (NYSE:TOL), recognized as a leader in luxury home construction, has unveiled plans for its upcoming community, Foxtail Crossing. This new venture aims to cater to the growing demand for upscale living spaces while providing an array of customization options for home buyers. Located conveniently at the...

Continue Reading